Progyny (PGNY) Liabilities and Shareholders Equity (2018 - 2026)

Progyny (PGNY) has 9 years of Liabilities and Shareholders Equity data on file, last reported at $698.3 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 4.37% year-over-year to $698.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 billion (up 11.16% YoY) and the FY2025 annual result came in at $742.4 million, up 22.29% from the prior year.
• Liabilities and Shareholders Equity declined to $698.3 million in Q1 2026 per PGNY's latest filing, from $742.4 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $795.2 million in Q3 2025 and bottomed at $415.5 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $681.5 million (2023), against an average of $649.8 million.
• The widest annual swing landed in 2023, when Liabilities and Shareholders Equity surged 56.36%; it then declined 19.76% in 2024.
• Tracing PGNY's Liabilities and Shareholders Equity over 5 years: stood at $543.0 million in 2022, then soared by 39.34% to $756.6 million in 2023, then decreased by 19.76% to $607.1 million in 2024, then increased by 22.29% to $742.4 million in 2025, then decreased by 5.94% to $698.3 million in 2026.
• Per Business Quant, the three latest PGNY Liabilities and Shareholders Equity figures stand at $698.3 million (Q1 2026), $742.4 million (Q4 2025), and $795.2 million (Q3 2025).

Peer Comparison